Halina Waś

ORCID: 0000-0003-2743-0337
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heme Oxygenase-1 and Carbon Monoxide
  • Cancer, Hypoxia, and Metabolism
  • Thermal Regulation in Medicine
  • Telomeres, Telomerase, and Senescence
  • Autophagy in Disease and Therapy
  • High Altitude and Hypoxia
  • Hemoglobin structure and function
  • Inflammatory mediators and NSAID effects
  • Epigenetics and DNA Methylation
  • Eicosanoids and Hypertension Pharmacology
  • Nanoplatforms for cancer theranostics
  • Neonatal Health and Biochemistry
  • Air Quality and Health Impacts
  • Glioma Diagnosis and Treatment
  • Genomics, phytochemicals, and oxidative stress
  • Photodynamic Therapy Research Studies
  • Cancer Cells and Metastasis
  • Peroxisome Proliferator-Activated Receptors
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Lymphatic System and Diseases
  • Cancer Immunotherapy and Biomarkers
  • Kruppel-like factors research
  • Cancer-related cognitive impairment studies
  • CRISPR and Genetic Engineering
  • Inflammatory Biomarkers in Disease Prognosis

Narodowy Instytut Leków
2023

Jagiellonian University
2008-2022

Wojskowy Instytut Medycyny Lotniczej
2017-2022

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego
2013-2019

Polish Academy of Sciences
2015-2017

Institute of Neurobiology
2015

Charles University
2010

University of Vienna
2010

University of Łódź
2010

Stromal cell–derived factor 1 (SDF-1) plays a major role in the migration, recruitment, and retention of endothelial progenitor cells to sites ischemic injury contributes neovascularization. We provide direct evidence demonstrating an important for heme oxygenase (HO-1) mediating proangiogenic effects SDF-1. Nanomolar concentrations SDF-1 induced HO-1 through protein kinase C ζ–dependent vascular growth factor–independent mechanism. SDF-1–induced tube formation migration was impaired...

10.1084/jem.20061609 article EN The Journal of Experimental Medicine 2007-03-05

Heme oxygenase-1 (HO-1, HMOX1) can prevent tumor initiation; while in various tumors, it has been demonstrated to promote growth, angiogenesis, and metastasis. Here, we investigated whether HMOX1 modulate microRNAs (miRNAs) regulate human non-small cell lung carcinoma (NSCLC) development.Stable overexpression NSCLC NCI-H292 cells up-regulated tumor-suppressive miRNAs, whereas significantly diminished the expression of oncomirs angiomirs. The most potently down-regulated was miR-378. also...

10.1089/ars.2013.5184 article EN Antioxidants and Redox Signaling 2013-04-26

Cancer cells can undergo stress-induced premature senescence, which is considered to be a desirable outcome of anticancer treatment. However, the escape from senescence and cancer cell repopulation give rise some doubts concerning effectiveness senescence-induced therapy. Similarly, it postulated that polyploidization connected with disease relapse. We postulate associated culprit atypical divisions leading regrowth. Accordingly, we aimed dissociate between these two phenomena. induced in...

10.1016/j.neo.2015.11.008 article EN cc-by-nc-nd Neoplasia 2015-12-01

Heme oxygenase-1 (HO-1), a cytoprotective, pro-angiogenic and anti-inflammatory enzyme, is strongly induced in injured tissues. Our aim was to clarify its role cutaneous wound healing. In wild type mice, maximal expression of HO-1 the skin observed on 2(nd) 3(rd) days after wounding. Inhibition by tin protoporphyrin-IX resulted retardation closure. Healing also delayed deficient where lack could lead complete suppression reepithelialization formation extensive lesions, accompanied impaired...

10.1371/journal.pone.0005803 article EN cc-by PLoS ONE 2009-06-03

Heme oxygenase-1 (HMOX1) is a cytoprotective enzyme degrading heme to biliverdin, iron ions, and carbon monoxide, whose expression induced in response oxidative stress. Its overexpression has been suggested as strategy improving survival of transplanted muscle precursors.Here we demonstrated that HMOX1 inhibits differentiation myoblasts modulates miRNA processing: downregulates Lin28 DGCR8, lowers the total pool cellular miRNAs, specifically blocks induction myomirs. Genetic or...

10.1089/ars.2011.3964 article EN Antioxidants and Redox Signaling 2011-08-09

Heme oxygenase-1 (HO-1) is an antioxidative, antiinflammatory, and cytoprotective enzyme that induced in response to cellular stress. The HO-1 promoter contains a (GT)n microsatellite DNA, the number of GT repeats can influence occurrence cardiovascular diseases. We elucidated effect this polymorphism on endothelial cells isolated from newborns different genotypes.On basis expression, we classified alleles into 3 groups: short (S) (most active, < or = 23), medium (moderately GT=24 28), long...

10.1161/atvbaha.110.207316 article EN Arteriosclerosis Thrombosis and Vascular Biology 2010-05-28

The diagnosis of glioblastoma (GBM), a most aggressive primary brain tumor with median survival 14.6 months, carries dismal prognosis. GBMs are characterized by numerous genetic and epigenetic alterations, affecting patient treatment response. Epigenetic mechanisms deregulated in GBM as result aberrant expression/activity enzymes, including histone deacetylases (HDAC) which remove acetyl groups from histones regulating chromatin accessibility. Nevertheless, the impact class/isoform-selective...

10.1186/s13148-018-0598-5 article EN cc-by Clinical Epigenetics 2019-01-17

Colorectal cancer (CRC) is the second leading cause of death among patients in Northern countries. CRC can reappear a long time after treatment. Recent clinical studies demonstrated that, response to chemotherapy, cells may undergo stress-induced premature senescence (SIPS), which typically results growth arrest. Nonetheless, these senescent were reported divide an atypical manner and thus contribute re-growth. Therefore, we examined if SIPS escape follow treatment with chemotherapeutics...

10.1080/15384047.2017.1385675 article EN Cancer Biology & Therapy 2017-10-20

Anticancer therapies that induce DNA damage tend to trigger senescence in cancer cells, a process known as therapy-induced (TIS). Such cells may undergo atypical divisions, thus contributing tumor re-growth. Accumulation of senescent reduces survival patients after chemotherapy. As interplays with autophagy, dynamic recycling process, we sought study whether inhibition autophagy interferes divisions TIS cells. We exposed human colon HCT116 repeated cycles chemotherapeutic agent - doxorubicin...

10.18632/oncotarget.14066 article EN Oncotarget 2016-12-21

Abstract Background HO-1 participates in the degradation of heme. Its products can exert unique cytoprotective effects. Numerous tumors express high levels indicating that this enzyme might be a potential therapeutic target. In study we decided to evaluate cytostatic/cytotoxic effects zinc protoporphyrin IX (Zn(II)PPIX), selective inhibitor and its antitumor activity combination with chemotherapeutics. Methods Cytostatic/cytotoxic Zn(II)PPIX were evaluated crystal violet staining clonogenic...

10.1186/1471-2407-8-197 article EN cc-by BMC Cancer 2008-07-11

Heme oxygenase-1 (HO-1) is an antioxidative and cytoprotective enzyme, which may protect neoplastic cells against anticancer therapies, thereby promoting the progression of growing tumors. Our aim was to investigate role HO-1 in cancer induction. Experiments were performed HO-1(+/+), HO-1(+/-), HO-1(-/-) mice subjected chemical induction squamous cell carcinoma with 7,12-dimethylbenz[a]anthracene phorbol 12-myristate 13-acetate. Measurements genes livers evidenced systemic oxidative stress...

10.1016/j.freeradbiomed.2011.07.025 article EN cc-by Free Radical Biology and Medicine 2011-08-14

Chemotherapy is the commonly used treatment for advanced lung cancer. However, it produces side effects such as development of chemoresistance. A possible responsible mechanism may be therapy-induced senescence (TIS). TIS cells display increased senescence-associated β-galactosidase (SA-β-gal) activity and irreversible growth arrest. recent data suggest that can reactivate their proliferative potential lead to cancer recurrence. Our previous study indicated reactivation proliferation by...

10.3389/fonc.2021.738385 article EN cc-by Frontiers in Oncology 2022-01-21

Proangiogenic enzyme thymidine phosphorylase (TP) is a promising target for anticancer therapy, yet its action in non-small cell lung carcinoma (NSCLC) not fully understood. To elucidate role NSCLC tumor growth, NCI-H292 mucoepidermoid cells and endothelial were engineered to overexpress TP by viral vector transduction. with altered expression of transcription factor Nrf2 or gene heme oxygenase-1 (HO-1) used study the regulation findings from pre-clinical models related data clinical...

10.1371/journal.pone.0097070 article EN cc-by PLoS ONE 2014-05-12

Natural compounds, such as resveratrol (Res), are currently used adjuvants for anticancer therapies. To evaluate the effectiveness of Res treatment ovarian cancer (OC), we screened response various OC cell lines to combined with cisplatin (CisPt) and Res. We identified A2780 cells most synergistically responding, thus optimal further analysis. Because hypoxia is hallmark solid tumor microenvironment, compared effects alone in combination CisPt (pO2 = 1%) vs. normoxia 19%). Hypoxia caused an...

10.3390/ijms24065715 article EN International Journal of Molecular Sciences 2023-03-16
Coming Soon ...